TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

DV PLATFORM

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

DV PLATFORM

ST13

US500000097537453

Classe

42

Pedido

97537453

Registro

7348343

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

28

Atualização mais recente

26/04/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

42

Data de depósito

05/08/2022

Data de registro

02/04/2024

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

02/04/2024

Última transação

26/04/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Fundamento do pedido

Intent to use

Primeiro uso

31/10/2022

Primeiro uso no comércio

14/11/2022

Código do desenho

4

Tipo de titular

03

Localização do titular

Allentown, NJ, US

Examinador

DIBLE, JONATHON I

Unidade examinadora

M20

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

SciMar ONE, Inc.

Representantes

Neil M. Barnes Neo IP

Classificação técnica

Classes Nice

Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 42

Software as a service (SAAS) services featuring software using artificial intelligence for use in pharmaceutical drug development, metadata tagging in the fields of healthcare and pharmaceuticals, identifying biomarkers, identifying mutations, identifying comorbidities, identifying side effects of drugs, identifying efficacy of drugs, identifying clinical study designs, identifying pharmacokinetics (PK), identifying study arms for clinical studies, identifying patient characteristics, identifying disease characteristics, identifying labs, identifying resistance markers, identifying disease therapies, vaccine development, diagnostics development in the fields of healthcare and pharmaceuticals, analyzing clinical data in the fields of healthcare and pharmaceuticals, analyzing clinical data in healthcare databases, health economics and outcomes research (HEOR) in the fields of healthcare and pharmaceuticals, conducting clinical trials in the fields of healthcare and pharmaceuticals, accessing and analyzing competitive intelligence information in the fields of healthcare and pharmaceuticals, organizing, managing, and tracking data during development of a drug and over the life of a drug, creating and updating clinical guidelines in the fields of healthcare and pharmaceuticals, personalizing treatment options in the fields of healthcare and pharmaceuticals, and patient identification in the fields of healthcare and pharmaceuticals; Platform as a service (PAAS) services featuring software platforms using artificial intelligence for use in pharmaceutical drug development, metadata tagging in the fields of healthcare and pharmaceuticals, identifying biomarkers, identifying mutations, identifying comorbidities, identifying side effects of drugs, identifying efficacy of drugs, identifying clinical study designs, identifying pharmacokinetics (PK), identifying study arms for clinical studies, identifying patient characteristics, identifying disease characteristics, identifying labs, identifying resistance markers, identifying disease therapies, vaccine development, diagnostics development in the fields of healthcare and pharmaceuticals, analyzing clinical data in the fields of healthcare and pharmaceuticals, analyzing clinical data in healthcare databases, health economics and outcomes research (HEOR) in the fields of healthcare and pharmaceuticals, conducting clinical trials in the fields of healthcare and pharmaceuticals, accessing and analyzing competitive intelligence information in the fields of healthcare and pharmaceuticals, organizing, managing, and tracking data during development of a drug and over the life of a drug, creating and updating clinical guidelines in the fields of healthcare and pharmaceuticals, personalizing treatment options in the fields of healthcare and pharmaceuticals, and patient identification in the fields of healthcare and pharmaceuticals

Publicações

Histórico de despachos e eventos da marca no USPTO.

28 publicações encontradas

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

24/04/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

24/04/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

24/04/2026

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

02/04/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

02/04/2024

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

28/02/2024

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

27/02/2024

SUPC

STATEMENT OF USE PROCESSING COMPLETE

24/02/2024

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

24/02/2024

IUAF

USE AMENDMENT FILED

01/02/2024

EISU

TEAS STATEMENT OF USE RECEIVED

01/02/2024

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

12/12/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

17/10/2023

PUBO

PUBLISHED FOR OPPOSITION

17/10/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

27/09/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/09/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/09/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

31/08/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

31/08/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

27/07/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

27/07/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

27/07/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

03/06/2023

GNRT

NON-FINAL ACTION E-MAILED

03/06/2023

CNRT

NON-FINAL ACTION WRITTEN

03/06/2023

DOCK

ASSIGNED TO EXAMINER

23/05/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

28/08/2022

NWAP

NEW APPLICATION ENTERED

09/08/2022

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace DV PLATFORM ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.